A screen of human-infecting viruses identified extensive examples of viral proteins that resembled human sequences, which ...

De novo antibody design has been one of the major challenges in AI-based drug discovery, requiring atomic-level precision to ...

The global bispecific antibody (BsAb) market has witnessed significant growth, with 17 bispecific antibody therapies already ...

Adding immunotherapy to new KRAS inhibitors boosted responses in preclinical models, setting the stage for future trials of the combination strategy.

The global polyclonal antibody market is poised for significant expansion in the coming decade, driven by increasing ...

Wells Fargo analyst Yanan Zhu lowered the firm’s price target on Voyager Therapeutics (VYGR) to $10 from $12 and keeps an Overweight rating on ...

People with Crohn's disease and related joint inflammation linked to immune system dysfunction have distinct gut bacteria or microbiota, with the bacterium Mediterraneibacter gnavus being a potential ...

A live webcast of the fireside chat may be accessed by visiting the Events page of the Company’s website at www.promisneurosciences.com, and will be available for at least 30 days following the event.

Not long after the first flu shot was introduced in 1945 by University of Michigan virologist Thomas Francis and his ...

We plan to have our entire catalog mapped in the near future," said Dr. Jason Li, CEO at Proteintech. "With more epitopes mapped, we hope the days when scientists have to try multiple antibodies for ...

Proteintech, a global leader in antibodies and life science solutions, is excited to announce additional product ...

Peptide-based vaccines deliver tumor-specific antigens to dendritic cells (DCs), triggering tumor-targeted T-cell responses. A peptide-peptide conjugate technology previously developed by researchers ...